Uncategorized
Revolution Medicines leads latest wave of stock offerings, totaling $1.5B
Another stock offering blitz is adding more fuel to biotech investors’ belief in the sector.
Revolution Medicines anchored Monday’s offering surge, while Spyre Therapeutics and Allogene Therapeutics also joined in. The trio is planning to …